03 January 2019 10:15 CET

Karo Intressenter AB publishes supplement to offer document regarding its public cash offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

22 June 2022
EQT Private Equity to sell Facile.it, Italy’s largest online price comparison platform, to Silver Lake
22 June 2022
EQT Private Equity to acquire SPT Labtech, a fast-growing laboratory automation player focused on low-volume liquid handling technology for GBP 650 million from Battery Ventures
14 June 2022
Partnering to accelerate impact
07 June 2022
EQT Private Equity and Mubadala to acquire Envirotainer, the leading global provider of mission-critical biopharma transport services
01 June 2022
Bulletin from EQT AB’s Annual Shareholders’ Meeting 2022